Who are we?
Our Team
abi collaborates with a network of external experts across diverse sectors of health innovation
Pr Hechmi Louzir
Chairman of the Executive Board
Independent consultant, former Director of the Pasteur Institute of Tunis.
Mariem Hanachi
Project Manager
PhD in Bioinformatics, former researcher at the Pasteur Institute of Tunis.
Marwa Louati
Project Manager
abi is supported by a Scientific Advisory Board (SAB) composed of five internationally recognized experts from leading research institutions and biotech companies.
Pr Marc Bonneville
médicales et scientifiques,
Institut Mérieux, France
Dr Hela Kallel
de vaccins,
Univercells, Belgique
Dr Isabelle Buckle
Présidente, transfert de technologie,
Institut Pasteur, Paris
Our Mission
At abi, our core focus lies in the identification, development, and valorization of biotechnological innovations within the healthcare sector. Our mission is to transform scientific discoveries into viable solutions, bridging the gap between research and industry to bring groundbreaking treatments to market.
Scientific Pipeline
Our model relies on three strategic pillars :
Projects identified from research initiatives coordinated by the ABI team in collaboration with its partners.
Approach
abi’s approach is concise and straightforward, based on a LiMLo licensing model
Buisness Model
Our model relies on the funding of technology maturation, accompanied by tailored support from ABI. Upon success, the revenue generated from the exploitation of the outcomes are equitably shared between ABI and its partners.
Detection, Selection & License In
We identify and select high-potential innovations from the academic world through a rigorous selection process based on recommendations from the Scientific Advisory Board (SAB).
Co-development and Maturation
We accelerate the maturation of selected technologies to validate their potential and ensure readiness for technology transfer, while securing market access.
Tech Transfer & License Out
We transfer technologies to industrial partners or through create startups, ensuring their commercialization.
Call for Projects
Biotechnology and Health innovations
You have a biotech project focused on human or animal health?
Apply now and gain our strategic support!
Key Dates
Application deadline: June 15, 2025
Project pre-selection: June 28, 2025
Results announcement: July 15, 2025
Start of pre-funding: September 1, 2025
Questions? Contact us at:
contact@ab-i.tech
🔒 Confidentiality of Data and Projects
Personal information as well as projects submitted in this call remains strictly confidential. They will be used exclusively for the evaluation, selection, and follow-up of the projects. No information will be shared without the prior consent of the project owner.
Our Partners
English 
French